First-in-Human Evaluation of GRN-300 in Subjects With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancers.
Clinical trial NCT04711161 · SUSPENDED
Trial details
- NCT number
- NCT04711161
- Sponsor
- Green3Bio, Inc.
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-21
- Primary completion
- 2024-12-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.